Evolution of the Average Target: UiPath, Inc.

Evolution of the Target Price: UiPath, Inc.

Changes in Analyst Recommendations: UiPath, Inc.

cbbddc3ea82620d48e7.shQ0QmSFDOlrplkrbcM7dlGgqI3A71ChToHsQHTyQPY.83VyLV3vSLYClxR_Pa1JIQ7o2N-KiwmYfcOYASeUdsD8bQEvHcdA0CX2bQ~8453482d1e258cbf9b6e4734419f4a65
09-23 UiPath's Transition to Business Orchestration, Automation Technologies Remains 'Show-Me Story,' RBC Says MT
09-23 UBS Adjusts UiPath Price Target to $15 From $19, Maintains Neutral Rating MT
09-23 RBC Cuts Price Target on UiPath to $15 From $17, Keeps Sector Perform Rating MT
09-23 Truist Cuts Price Target on UiPath to $14 From $17, Keeps Hold Rating MT
09-23 Analyst recommendations: AMD, Microsoft, Domino's Pizza, Hewlett Packard… Zonebourse
09-08 Citigroup Initiates UiPath at Buy With $23 Price Target MT
09-04 UiPath's AI-Driven Deal Momentum, new Product Traction in Q2 are Encouraging, RBC Says MT
09-04 BofA Adjusts Price Target on UiPath to $15 From $13 MT
09-04 Canaccord Genuity Downgrades UiPath to Hold From Buy, Raises Price Target to $17 From $15 MT
09-04 RBC Raises Price Target on UiPath to $17 From $15, Keeps Sector Perform Rating MT
09-04 Truist Securities Adjusts Price Target on UiPath to $17 From $12, Keeps Hold Rating MT
09-04 Analyst recommendations: Microsoft, DocuSign, Intuit, Lululemon Athletica, Zscaler… Zonebourse
08-31 UBS Adjusts UiPath Price Target to $19 From $12, Maintains Neutral Rating MT
08-31 Analyst recommendations: Adobe, Marvell Technology, Salesforce, UiPath… Zonebourse
06-29 UBS Adjusts Price Target on UiPath to $12 From $13, Maintains Neutral Rating MT
05-29 UiPath Sees Continued AI Deal Momentum, Improved Customer Retention, RBC Says MT
05-29 BofA Adjusts Price Target on UiPath to $13 From $12 MT
05-22 Workday Results Don't Suggest Enough of 'Growth Improvement' to Sustain Re-Rating, UBS Says MT
05-15 RBC Cuts Price Target on UiPath to $12 From $14, Keeps Sector Perform Rating MT
03-12 UiPath's AI Momentum Drives ARR to $200 Million, RBC Says MT
03-12 UiPath Results Signal Stability, AI Adoption Key to Faster Growth, Morgan Stanley Says MT
03-12 UBS Adjusts Price Target on UiPath to $13 From $17, Maintains Neutral Rating MT
03-12 Morgan Stanley Cuts Price Target on UiPath to $17 From $19, Keeps Equalweight Rating MT
03-12 Truist Cuts Price Target on UiPath to $12 From $17, Keeps Hold Rating MT
03-12 Analyst recommendations: General Mills, Murphy Oil, Oxy, Exxon Mobil, UiPath… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.32%
+1.97%
+13.44%
+30.51%
+32.17%
+52.11%
+2.87%
-9.52%
+38.83%
Average +19.74%
Weighted average by Cap. +14.84%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
12.60USD
Average target price
15.91USD
Spread / Average Target
+26.27%
High Price Target
23.00USD
Spread / Highest target
+82.54%
Low Price Target
10.98USD
Spread / Lowest Target
-12.86%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA